Twinrix

Revision as of 15:51, 2 January 2013 by Aditya Govindavarjhulla (talk | contribs) (→‎Overview)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Twinrix is a vaccine against hepatitis A and hepatitis B. Twinrix is administered over three doses.

The name was created because it is a mixture of two earlier vaccines - Havrix, an inactivated-virus Hepatitis A vaccine, and ENGERIX-B, a recombinant Hepatitis B vaccine.

The CDC reports that clinical trials found the following levels of protection against Hep A and Hep B one month after each dose[1]:
A: 93.8% 98.8% 99.9%
B: 30.8% 78.2% 98.5%

GlaxoSmithKline claims that its studies found 70% of subjects had antibodies against hepatitis B a month after just the first dose, however.[2]

TWINRIX, HAVRIX and ENGERIX-B are registered trademarks of GlaxoSmithKline; if the same vaccine is available from others, it will have another name.

References


Template:Pharma-stub

de:Twinrix sv:Twinrix